(Q47697426)

4 February 2018

title

Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis (English)

1 reference

4 February 2018

0 references

RoseMarie Stillie

1

1 reference

4 February 2018

Andrew W Stadnyk

series ordinal

2

1 reference

4 February 2018

publication date

1 October 2009

1 reference

4 February 2018

Inflammatory Bowel Diseases

published in

1 reference

4 February 2018

volume

15

1 reference

4 February 2018

issue

10

1 reference

4 February 2018

page(s)

1515-1525

1 reference

4 February 2018

TNF-mediated inflammatory disease.

cites work

1 reference

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

21 January 2018

1 reference

The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor

21 January 2018

1 reference

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice

21 January 2018

1 reference

Critical appraisal of the current practice in murine TNBS-induced colitis

21 January 2018

1 reference

Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis

21 January 2018

1 reference

Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice

21 January 2018

1 reference

Differential role of tumor necrosis factor receptors in TNBS colitis

21 January 2018

1 reference

The role of the tumor necrosis factor receptor in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice

21 January 2018

1 reference

Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients

21 January 2018

1 reference

TNFalpha blockade in human diseases: mechanisms and future directions

21 January 2018

1 reference

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

21 January 2018

1 reference

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis

21 January 2018

1 reference

Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice

21 January 2018

1 reference

Suppression of experimental colitis by intestinal mononuclear phagocytes.

21 January 2018

1 reference

Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease

21 January 2018

1 reference

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine

21 January 2018

1 reference

TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis

21 January 2018

1 reference

Epithelial NEMO links innate immunity to chronic intestinal inflammation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20951

1 reference

4 February 2018

1 reference

4 February 2018